Open AccessAbstract 4096: Stage-defined, transgenic immunocompetent mouse model (ASV-B) to investigate new drugs for hepatocellular carcinoma
Author(s) -
Annemilaï TijerasRaballand,
Patricia Hainaud,
Christian Hobeika,
Clarisse Eveno,
Marc Pocard,
Philippe Bonnin,
Valérie Paradis,
Mohamed Bouattour,
Éric Raymond,
Armand de Gramont,
Évelyne Dupuy,
Sandrine Faivre
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-4096
Subject(s) - hepatocellular carcinoma , genetically modified mouse , transgene , medicine , liver cancer , oncogene , stage (stratigraphy) , cancer research , pathology , malignancy , cancer , desmin , carcinogenesis , hyperplasia , biology , immunohistochemistry , cell cycle , vimentin , paleontology , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom